Timing and priorities for cystic fibrosis patients candidates to long transplantation

被引:13
作者
Venuta, F
Rendina, EA
De Giacomo, T
Quattrucci, S
Vizza, D
Ciccone, AM
Guarino, E
Della Rocca, G
Ricci, C
机构
[1] Univ Rome La Sapienza, Policlin Umberto I, Cattedra Chirurg Toracica, I-00100 Rome, Italy
[2] Univ Rome La Sapienza, Dept Pediat, I-00100 Rome, Italy
[3] Univ Rome La Sapienza, Dept Cardiol, I-00100 Rome, Italy
[4] Univ Rome La Sapienza, Dept Anaesthesiol, I-00100 Rome, Italy
关键词
bilateral lung transplantation; cystic fibrosis; cardiopulmonary hemodynamic criteria; options for transplantation;
D O I
10.1055/s-2008-1071213
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Bilateral lung transplantation is actually considered a valuable option for patients with endstage lung disease related to cystic fibrosis. Timing is crucial to transplant successfully as many patients as possible and it is mainly based on the progressive worsening of pulmonary function tests and quality of life. We reviewed the charts of all patients accepted for lung transplantation at our Institution, in order to assess the role of several functional and demographic parameters; we compared the group of patients able to successfully wait for transplantation (Group A) with patients dying on the waiting list (Group B). Twenty-eight patients were accepted: 15 were successfully transplanted (2 at other institutions) (mean waiting time: 117 days), 7 died waiting (mean waiting time: 108 days) and 6 are still on the list. We recorded FEV-1, FVC, PaO2, PaCO2, supplemental O-2 requirement, 6-minute walking test, right ventricular ejection fraction (RVEF) and cardio-pulmonary hemodynamics measured at right heart catheterization; we recorded also age at time of diagnosis and at time of evaluation, sex, weight and Schwachman score. These parameters were compared between Group A and B. Age at time of evaluation, sex, weight and Schwachman score did not present any difference between the two groups, as well as pulmonary function tests, PaO2, 6-minute walk test and RVEF. A statistically significant difference was found in terms of PaCO2 (43.9 +/- 9.3 in Group A vs 69.1 +/- 32.4 in Group B, heart rate at rest (102 +/- 21 vs 131 +/- 12) mean pulmonary artery pressure (20.6 +/- 2.9 vs 36 +/- 15.7), pulmonary vascular resistances (350 +/- 96 vs 460 +/- 119.4), cardiac index (3.2 +/- 0.6 vs 5.4 +/- 0.9). On the base of our initial experience we conclude that a careful evaluation of CF candidates for lung transplantation is recommended. A deterioration of pulmonary function tests and quality of life are useful parameters to accept patients in the waiting list; however priority should be attributed also on the base of cardio-pulmonary hemodynamics. A larger series of patients is required to draw definitive conclusions.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 14 条
[1]   ANALYSIS OF CYSTIC-FIBROSIS REFERRALS FOR LUNG TRANSPLANTATION [J].
CIRIACO, P ;
EGAN, TM ;
CAIRNS, EL ;
THOMPSON, JT ;
DETTERBECK, FC ;
PARADOWSKI, LJ .
CHEST, 1995, 107 (05) :1323-1327
[2]  
CROPP G, 1984, CYSTIC FIBROSIS F, V25, P17
[3]  
DELEVAL MR, 1991, J THORAC CARDIOV SUR, V101, P633
[4]  
Egan T M, 1992, Semin Respir Infect, V7, P227
[5]  
EGAN TM, 1991, CHEST, pS28
[6]  
HOUSENPUND JD, 1997, J HEART LUNG TRANSPL, V16, P691
[7]  
Kadikar A, 1997, J HEART LUNG TRANSPL, V16, P313
[8]   PREDICTION OF MORTALITY IN PATIENTS WITH CYSTIC-FIBROSIS [J].
KEREM, E ;
REISMAN, J ;
COREY, M ;
CANNY, GJ ;
LEVISON, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (18) :1187-1191
[9]   SELECTION AND EVALUATION OF RECIPIENTS FOR HEART-LUNG AND LUNG TRANSPLANTATION [J].
MARSHALL, SE ;
KRAMER, MR ;
LEWISTON, NJ ;
STARNES, VA ;
THEODORE, J .
CHEST, 1990, 98 (06) :1488-1494
[10]  
SCOTT J, 1988, LANCET, V2, P192